# Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting

> **NCT00246740** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 56 (actual)

## Conditions studied

- Coronary Artery Bypass Grafting
- Cardiopulmonary Bypass
- Reperfusion Injury

## Interventions

- **DRUG:** Periostat
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT00246740
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2008-05
- **Final completion:** 2009-05
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2017-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246740, "Protection of the Heart With Doxycycline During Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00246740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*